Literature DB >> 6202310

Pharmacology of an emulsion formulation of ICI 35 868.

J B Glen, S C Hunter.   

Abstract

Studies with an emulsion formulation of ICI 35 868 (2,6- diisopropylphenol ) indicate that this new formulation has anaesthetic properties in rats and mice, and haemodynamic effects in the mini-pig which are similar to those of the previously available Cremophor formulation. Administration of the emulsion formulation to dogs produced no untoward effect, whereas the Cremophor formulation produced a marked increase in plasma histamine concentration. In the mini-pig, no adverse response was produced by the repeated administration of the emulsion formulation of ICI 35 868, whereas the Cremophor formulation produced anaphylactoid responses when a second injection was given 1 week after an uneventful first exposure to this formulation. Behavioural responses in the rat suggest that the emulsion formulation may produce less discomfort on i.v. injection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202310     DOI: 10.1093/bja/56.6.617

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  22 in total

1.  Plasma histamine levels during induction of anesthesia with propofol in dogs.

Authors:  H Mitsuhata; R Shimizu
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

2.  Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia.

Authors:  Irena Loryan; Marja Lindqvist; Inger Johansson; Masahiro Hiratsuka; Ilse van der Heiden; Ron H N van Schaik; Jan Jakobsson; Magnus Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  2011-10-18       Impact factor: 2.953

3.  AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.

Authors:  Talmage D Egan; Shinju Obara; Thomas E Jenkins; Sarah S Jaw-Tsai; Shanti Amagasu; Daniel R Cook; Scott C Steffensen; David T Beattie
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

4.  The 2018 Lasker~DeBakey Clinical Medical Research Award recognizes John Baird Glen for the discovery of propofol.

Authors:  Elyse Dankoski
Journal:  J Clin Invest       Date:  2018-09-11       Impact factor: 14.808

5.  Preparation and anesthetic properties of propofol microemulsions in rats.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Todd Grand; Dinesh O Shah; Nikolaus Gravenstein; Susan P McGorray; Donn M Dennis
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

6.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

7.  Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion.

Authors:  Y Wang; G M Mesfin; C A Rodríguez; J G Slatter; M R Schuette; A L Cory; M J Higgins
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

8.  A new intravenous anesthetic agent: propofol.

Authors:  T Duke
Journal:  Can Vet J       Date:  1995-03       Impact factor: 1.008

9.  Action of propofol on central sympathetic mechanisms controlling blood pressure.

Authors:  A V Krassioukov; A W Gelb; L C Weaver
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 10.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.